GLENMEDE TRUST CO NA - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 64 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2019$0310.0%0.00%
Q2 2019$0310.0%0.00%
Q1 2019$0310.0%0.00%
Q4 2018$0310.0%0.00%
Q3 2017$0310.0%0.00%
Q2 2017$0310.0%0.00%
Q1 2017$0310.0%0.00%
Q4 2016$0310.0%0.00%
Q3 2016$0310.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders